SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-028869
Filing Date
2023-02-09
Accepted
2023-02-08 21:39:37
Documents
14
Period of Report
2023-02-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d382775d8k.htm   iXBRL 8-K 30667
2 EX-99.1 d382775dex991.htm EX-99.1 1645
6 GRAPHIC g382775ex99_1p1g1.jpg GRAPHIC 334671
  Complete submission text file 0001193125-23-028869.txt   621488

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eras-20230208.xsd EX-101.SCH 2834
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eras-20230208_lab.xml EX-101.LAB 18736
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eras-20230208_pre.xml EX-101.PRE 11696
8 EXTRACTED XBRL INSTANCE DOCUMENT d382775d8k_htm.xml XML 3460
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

IRS No.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40602 | Film No.: 23600873
SIC: 2834 Pharmaceutical Preparations